Fenretinide in Treating Patients With Cervical Neoplasia - Contacts and Locations

Home

Fenretinide in Treating Patients With Cervical Neoplasia

This study is ongoing, but not recruiting participants.

Study NCT00003075. Last updated on September 4, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003075

Locations


United States, Texas
	University of Texas - MD Anderson Cancer Center
	Houston, Texas, United States, 77030

Sponsors and Collaborators

M.D. Anderson Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Michele Follen, MD, PhD	M.D. Anderson Cancer Center